• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FIT 改变增加 CRC 筛查率:美国筛查外展计划评估。

Change to FIT increased CRC screening rates: evaluation of a US screening outreach program.

机构信息

Center for Health Research, Kaiser Permanente, Portland, OR 97227-1110, USA.

出版信息

Am J Manag Care. 2012 Oct;18(10):588-95.

PMID:23145804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3631273/
Abstract

OBJECTIVES

To compare completion rates of colorectal cancer screening tests within a health maintenance organization before and after widespread adoption of the fecal immunochemical test (FIT).

STUDY DESIGN

Retrospective cohort study.

METHODS

Using electronic medical records of 113,901 patients eligible for colorectal cancer screening, we examined test completion during 2 successive time periods among those who received an automated screening outreach call. The time periods were: 1) the "guaiac fecal occult blood test (gFOBT) era," a 15-month period during which only gFOBT was routinely offered, and 2) a 9-month "FIT era," when only a new FIT was routinely offered. In addition to analyzing completion rates, we analyzed the impact of practice-level variables and patient-level variables on overall screening completion during the 2 different observation periods.

RESULTS

The change from gFOBT to FIT in an integrated care delivery system increased the likelihood of screening completion by 7.7% overall, and the likelihood of screening with a fecal test by 8.9%. The greatest gains in screening completion using FIT were among women and elderly patients. Completion of FIT was not as strongly associated with medical office visits or with having a primary care provider as was screening with gFOBT.

CONCLUSIONS

Adoption of FIT within an integrated care system increased completion of colon cancer screening tests within a 9-month assessment period, compared with a previous 15-month gFOBT era. Higher completion rates of the FIT may allow for more effective dissemination of programs to increase colorectal cancer screening through centralized outreach programs.

摘要

目的

比较在卫生维护组织中广泛采用粪便免疫化学检测(FIT)前后结直肠癌筛查检测的完成率。

研究设计

回顾性队列研究。

方法

利用 113901 名符合结直肠癌筛查条件的患者的电子病历,我们在接受自动筛查外拨电话的患者中,检查了连续两个时间段内的检测完成情况。时间段为:1)“愈创木脂粪便潜血试验(gFOBT)时代”,这是一个 15 个月的时期,仅常规提供 gFOBT;2)9 个月的“FIT 时代”,仅常规提供新的 FIT。除了分析完成率外,我们还分析了实践水平变量和患者水平变量对两个不同观察期内总体筛查完成情况的影响。

结果

在综合医疗服务提供系统中,从 gFOBT 转为 FIT 总体上增加了 7.7%的筛查完成率,粪便检测的筛查率增加了 8.9%。在女性和老年患者中,使用 FIT 进行筛查的完成率增加幅度最大。与 gFOBT 相比,FIT 完成情况与医疗就诊次数或有初级保健提供者的关联不那么密切。

结论

在综合医疗系统中采用 FIT 可在 9 个月的评估期内增加结肠癌筛查检测的完成率,而之前的 15 个月 gFOBT 时代则没有。FIT 更高的完成率可能允许通过集中外展计划更有效地传播项目,以增加结直肠癌的筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b825/3631273/66ab6747a01b/nihms444651f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b825/3631273/66ab6747a01b/nihms444651f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b825/3631273/66ab6747a01b/nihms444651f1.jpg

相似文献

1
Change to FIT increased CRC screening rates: evaluation of a US screening outreach program.FIT 改变增加 CRC 筛查率:美国筛查外展计划评估。
Am J Manag Care. 2012 Oct;18(10):588-95.
2
Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.在大型医疗机构中,用粪便免疫化学检测替代愈创木脂粪便潜血试验可增加筛查人数的比例。
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1265-1270.e1. doi: 10.1016/j.cgh.2017.01.025. Epub 2017 Feb 4.
3
Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.2015 - 2016年阿拉伯联合酋长国阿布扎比门诊医疗服务诊所的结直肠癌筛查
BMC Cancer. 2021 Aug 6;21(1):897. doi: 10.1186/s12885-021-08623-9.
4
Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.在一项有组织的结直肠癌筛查计划中,免疫化学粪便潜血试验与愈创木脂粪便潜血试验的纵向依从性比较。
Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19.
5
Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.曼哈顿北部未参保人群中基于粪便检测的结直肠癌筛查
Am J Prev Med. 2014 Aug;47(2):182-7. doi: 10.1016/j.amepre.2014.03.011. Epub 2014 Jun 17.
6
Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.人口健康推广时代初级保健就诊与结直肠癌筛查结果之间的关联
J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.
7
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.结肠镜检查外展与粪便免疫化学检测外展对结直肠癌筛查完成率的影响:一项随机临床试验。
JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389.
8
Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.美国四个大型医疗保健系统中重复粪便免疫化学和潜血检测筛查的模式和预测因素。
Am J Gastroenterol. 2018 May;113(5):746-754. doi: 10.1038/s41395-018-0023-x. Epub 2018 Feb 27.
9
National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.全国性调查:影响结直肠癌筛查偏好的患者因素。
Cancer Prev Res (Phila). 2021 May;14(5):603-614. doi: 10.1158/1940-6207.CAPR-20-0524. Epub 2021 Apr 22.
10
Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.季节性变化并不影响粪便免疫化学检测在结直肠癌筛查中相对于愈创木脂法检测的优越性。
Int J Cancer. 2015 Apr 15;136(8):1827-34. doi: 10.1002/ijc.29187. Epub 2014 Sep 18.

引用本文的文献

1
Understanding ethnic inequalities in cancer diagnostic intervals: a cohort study of patients presenting suspected cancer symptoms to GPs in England.了解癌症诊断间隔中的种族不平等:一项针对在英格兰向全科医生呈现疑似癌症症状患者的队列研究。
Br J Gen Pract. 2025 May 2;75(754):e333-e340. doi: 10.3399/BJGP.2024.0518. Print 2025 May.
2
Multi-level predictors of being up-to-date with colorectal cancer screening.多层面预测因素与结直肠癌筛查的及时性。
Cancer Causes Control. 2023 Dec;34(Suppl 1):187-198. doi: 10.1007/s10552-023-01723-w. Epub 2023 Jun 7.
3
Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.

本文引用的文献

1
Issues related to colorectal cancer and colorectal cancer screening practices in women.与女性结直肠癌和结直肠癌筛查实践相关的问题。
Gastroenterol Clin North Am. 2011 Jun;40(2):415-26, ix. doi: 10.1016/j.gtc.2011.03.001. Epub 2011 Apr 13.
2
Preferences for ethnicity and sex of endoscopists in a Hispanic population in the United States.美国西班牙裔人群对内镜医生的种族和性别偏好。
Gastrointest Endosc. 2011 Jan;73(1):89-97, 97.e1-4. doi: 10.1016/j.gie.2010.09.008.
3
Longitudinal adherence with fecal occult blood test screening in community practice.
基于模型的 COVID-19 大流行期间结直肠癌筛查和结果的估计。
JAMA Netw Open. 2021 Apr 1;4(4):e216454. doi: 10.1001/jamanetworkopen.2021.6454.
4
Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review.大规模邮寄粪便免疫化学试验用于结直肠癌筛查外展项目的患者选择:系统评价。
J Med Screen. 2021 Dec;28(4):379-388. doi: 10.1177/0969141321997482. Epub 2021 Mar 8.
5
The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program.在加拿大结肠癌筛查项目中从愈创木脂粪便潜血试验过渡到粪便免疫化学试验的影响
J Can Assoc Gastroenterol. 2020 Aug;3(4):177-184. doi: 10.1093/jcag/gwz009. Epub 2019 Apr 11.
6
A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.基于多层面拟合的质量改进举措,提升管理式医疗人群的结直肠癌筛查率。
Clin Transl Gastroenterol. 2018 Sep 4;9(8):177. doi: 10.1038/s41424-018-0046-z.
7
Colorectal Cancer Screening Completion Among Individuals With and Without Mental Illnesses: A Comparison of 2 Screening Methods.患有和未患有精神疾病个体的结直肠癌筛查完成情况:两种筛查方法的比较
Am J Health Promot. 2018 May;32(4):925-931. doi: 10.1177/0890117116686573. Epub 2017 Jan 27.
8
Ten-Year Trends in Preventive Service Use Before and After Prostate Cancer Diagnosis: A Comparison with Noncancer Controls.前列腺癌诊断前后预防性服务使用情况的十年趋势:与非癌症对照的比较。
Perm J. 2017;21:16-184. doi: 10.7812/TPP/16-184.
9
Community-Based Colorectal Cancer Screening in a Rural Population: Who Returns Fecal Immunochemical Test (FIT) Kits?基于社区的农村人群结直肠癌筛查:谁返回粪便免疫化学检测(FIT)试剂盒?
J Rural Health. 2017 Sep;33(4):371-374. doi: 10.1111/jrh.12210. Epub 2016 Sep 21.
10
Human Blood Autoantibodies in the Detection of Colorectal Cancer.用于检测结直肠癌的人血自身抗体
PLoS One. 2016 Jul 6;11(7):e0156971. doi: 10.1371/journal.pone.0156971. eCollection 2016.
社区实践中粪便潜血试验筛查的纵向依从性。
Ann Fam Med. 2010 Sep-Oct;8(5):397-401. doi: 10.1370/afm.1133.
4
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.随着时间的推移,医疗保险参保者的初级保健、医疗保健的经济障碍和结直肠癌筛查测试的使用情况。
Ann Fam Med. 2010 Jul-Aug;8(4):299-307. doi: 10.1370/afm.1112.
5
Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.生命体征:50-75 岁成年人的结直肠癌筛查-美国,2008 年。
MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):808-12.
6
Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey.美国癌症筛查的数据和趋势:来自 2005 年全国健康访谈调查的结果。
Cancer. 2010 Oct 15;116(20):4872-81. doi: 10.1002/cncr.25215.
7
Automated telephone calls improved completion of fecal occult blood testing.自动电话通知提高了粪便潜血检测的完成率。
Med Care. 2010 Jul;48(7):604-10. doi: 10.1097/MLR.0b013e3181dbdce7.
8
Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.在平均风险的结直肠癌筛查人群中,基于愈创木脂的和定量免疫化学粪便隐血检测的比较。
Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25.
9
Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.粪便免疫化学试验比愈创木脂粪便潜血试验的结直肠癌筛查依从性更高:一项随机对照试验。
Prev Med. 2010 May-Jun;50(5-6):297-9. doi: 10.1016/j.ypmed.2010.03.010. Epub 2010 Mar 20.
10
Colorectal cancer screening barriers and facilitators in older persons.老年人结直肠癌筛查的障碍和促进因素。
Prev Med. 2010 Jan-Feb;50(1-2):3-10. doi: 10.1016/j.ypmed.2009.12.005. Epub 2009 Dec 16.